An iron-based T1 contrast agent made of iron-phosphate complexes: In vitro and in vivo studies

[1]  A. Roig,et al.  Investigations of the stability of {[(tacn)6Fe8(μ3-O)2(μ2-OH)12]Br7(H2O)}Br · 8H2O (Fe8) cluster in aqueous solution by spectroscopic and magnetic methods , 2006 .

[2]  J. Bulte,et al.  Instant MR labeling of stem cells using magnetoelectroporation , 2005, Magnetic resonance in medicine.

[3]  C. Arús,et al.  In vitro characterization of an Fe8 cluster as potential MRI contrast agent , 2005, NMR in biomedicine.

[4]  P. Robert,et al.  Distribution of gadomelitol in a human breast tumor model in mice , 2005, Magnetic Resonance Materials in Physics, Biology and Medicine.

[5]  F. Locatelli,et al.  Incidence and pathogenesis of tumor lysis syndrome. , 2005, Contributions to nephrology.

[6]  David R Vera,et al.  Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. , 2004, Academic radiology.

[7]  High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[8]  D. Fiorani,et al.  Synthesis, morphological-structural characterization and magnetic properties of amorphous iron (III)-oxyhydroxy-phosphate nanoparticles , 2004 .

[9]  Martha H Meyer,et al.  The genomic response of the mouse kidney to low-phosphate diet is altered in X-linked hypophosphatemia. , 2004, Physiological genomics.

[10]  S. Laurent,et al.  Synthesis and physicochemical characterization of Gd-DTPA-B(sLex)A, a new MRI contrast agent targeted to inflammation. , 2004, Bioconjugate chemistry.

[11]  A. Barge,et al.  Magnetic resonance imaging visualization of targeted cells by the internalization of supramolecular adducts formed between avidin and biotinylated Gd3+ chelates , 2004, JBIC Journal of Biological Inorganic Chemistry.

[12]  M. Décorps,et al.  Correlation between the occurrence of 1H‐MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development , 2003, NMR in biomedicine.

[13]  Glyn Johnson,et al.  Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathology , 2003, Magnetic resonance in medicine.

[14]  Dmitri Artemov,et al.  MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles , 2003, Magnetic resonance in medicine.

[15]  Silvio Aime,et al.  Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. , 2002, Angewandte Chemie.

[16]  E.,et al.  Paramagnetic Metal Complexes as Water Proton Relaxation Agents for NMR Imaging : Theory and Design , 2001 .

[17]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[18]  J. Davies,et al.  IRON(III)-BASED CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING , 1999 .

[19]  R. Muller,et al.  Intravascular and intracellular hepatic relaxivities of superparamagnetic particles: an isolated and perfused organ pharmacokinetics study. , 1998, Journal of magnetic resonance.

[20]  R. Keck,et al.  Iron-based second-sphere contrast agents for magnetic resonance imaging: development of a model system and evaluation of iron (III) tris (tironate) complex in rats. , 1996, Academic radiology.

[21]  M. Décorps,et al.  In Vivo, Ex Vivo, and In Vitro One‐ and Two‐Dimensional Nuclear Magnetic Resonance Spectroscopy of an Intracerebral Glioma in Rat Brain: Assignment of Resonances , 1994, Journal of neurochemistry.

[22]  G. Keilhoff,et al.  Comparison of double fluorescence staining and LDH-test for monitoring cell viability in vitro. , 1993, Neuroreport.

[23]  T. Kupka,et al.  Copper-D-penicillamine complex as potential contrast agent for MRI. , 1992, Magnetic resonance imaging.

[24]  S. Sirr,et al.  The preliminary evaluation of Mn DTPA as a potential contrast agent for nuclear magnetic resonance imaging. , 1986, American journal of physiologic imaging.

[25]  Elizabeth C. Theil,et al.  Fe(III).ATP complexes. Models for ferritin and other polynuclear iron complexes with phosphate. , 1985, The Journal of biological chemistry.

[26]  K. Wieghardt,et al.  HYDROLYSIS PRODUCTS OF MONOMERIC (C6H15N3)FECL3 AMINE COMPLEX: STRUCTURE OF THE OCTAMERIC IRON(III) CATION OF (((C6H15N3)6FE8(μ3-O)2(μ2-OH)12)BR7(H2O))BR.8H2O , 1984 .

[27]  G. Huttner,et al.  Hydrolysis Products of the Monomeric Amine Complex (C6H15N3)FeCl3: The Structure of the Octameric Iron(III) Cation of {[(C6H15N3)6Fe8(μ3‐O)2(μ2‐OH)12]Br7(H2O)}Br·8H2O , 1984 .

[28]  I. Hieger.  Studies in carcinogenesis. , 1965, British Journal of Cancer.

[29]  A. Seligman,et al.  Studies in Carcinogenesis: VIII. Experimental Production of Brain Tumors in Mice with Methylcholanthrene , 1939 .